A novel class of carbonic anhydrase inhibitors: Glycoconjugate benzene sulfonamides prepared by "click-tailing"

Journal of Medicinal Chemistry

Volumn 49, Issue 22, 2006, Pages 6539-6548

  Wilkinson, Brendan L ^a   Bornaghi, Laurent F ^a   Houston, Todd A ^a   Innocente, Alessio ^b   Supuran, Claudiu T ^b   Poulsen, Sally Ann ^a  

^a GRIFFITH UNIVERSITY   (Australia)

^b UNIVERSITY OF FLORENCE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ACETAZOLAMIDE; BENZENESULFONAMIDE DERIVATIVE; BRINZOLAMIDE; CARBOHYDRATE; CARBONATE DEHYDRATASE; CARBONATE DEHYDRATASE I; CARBONATE DEHYDRATASE II; CARBONATE DEHYDRATASE INHIBITOR; CARBONATE DEHYDRATASE IX; DICLOFENAMIDE; ETHOXZOLAMIDE; GLYCOCONJUGATE; INDISULAM; ISOENZYME; METHAZOLAMIDE; PACLITAXEL; TRIAZOLE;

ARTICLE; CANCER THERAPY; CATALYSIS; CLICK TAILING; DRUG CLASSIFICATION; DRUG POTENCY; DRUG SELECTIVITY; DRUG STRUCTURE; DRUG SYNTHESIS; ENZYME ACTIVE SITE; ENZYME ACTIVITY; ENZYME INHIBITION; HYPOXIA; IN VITRO STUDY; PROTEIN EXPRESSION; STEREOCHEMISTRY; STRUCTURE ACTIVITY RELATION; TUMOR;

BENZENE DERIVATIVES; CARBOHYDRATE SEQUENCE; CARBON DIOXIDE; CARBONIC ANHYDRASE INHIBITORS; GLYCOSYLATION; INDICATORS AND REAGENTS; ISOENZYMES; MOLECULAR SEQUENCE DATA; SULFONAMIDES;

EID: 33750471952     PISSN: 00222623     EISSN: None     Source Type: Journal    
DOI: 10.1021/jm060967z     Document Type: Article

References (30)

1. Supuran, C. T. Carbonic anhydrases: Catalytic and inhibition mechanism, distribution and physiological roles. In Carbonic Anhydrase: Its Inhibitors and Activators; Supuran, C. T., Scozzafava, A., Conway, J., Eds.: CRC Press: Boca Raton, FL, 2004: pp 1-24.
2. Scozzafava, A.; Supuran, C. T. Carbonic anhydrase inhibitors. Curr. Med. Chem. - Imm., Endoc. Metab. Agents 2001, 1, 61-97.
3. Supuran, C. T.; Scozzafava, A.; Casini, A. Carbonic anhydrase inibitors. Med. Res. Rev. 2003, 23, 146-189.
4. Pastorekova, S.; Parkkila, S.; Pastorek, J.; Supuran, C. T. Carbonic anhydrases: Current state of the art, therapeutic applications and future prospects. J. Enzymol. Inhib. Med. Chem. 2004, 19, 199-229.
5. Scozzafava, A.; Owa, T.; Mastrolorenzo, A.; Supuran, C. T. Anticancer and antiviral sulfonamides. Curr. Med. Chem. 2003, 10, 925-953.
6. Pastorekova, S.; Casini, A.; Scozzafava, A.; Vullo, D.; Pastorek, J.; Supuran, C. T. Carbonic anhydrase inhibitors: The first selective, membrane-impermeant inhibitors targeting the tumor-associated isozyme IX. Bioorg. Med. Chem. Lett. 2004, 14, 869-873.
7. Pastorekova, S.; Pastorek, J. Cancer-related carbonic anhydrase isozymes. In Carbonic Anhydrase-Its Inhibitors and Activators; Supuran, C. T., Scozzafava, A., Conway, J., Eds.; CRC Press: Boca Raton, FL, 2004; pp 253-280.
8. Erlanson, D. A.; McDowell, R. S.; O'Brien, T. Fragment-based drug discovery. J. Med. Chem. 2004, 47, 3463.
9. Lipinski, C. A.; Lombardo, F.; Dominy, B. W.; Feeney, P. J. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv. Drug Del. Rev. 2001, 46, 3-26.
10. ten Tije, A. J.; Verweij, J.; Loos, W. J.; Sparreboom, A. Pharmacological effects of formulation vehicles. Implications for cancer chemotherapy. Clin. Pharmacokinet. 2003, 42, 665-685.
11. Gradishar, W. J.; Tjulandin, S.; Davidson, N.; Shaw, H.; Desai, N.; Bhar, P.; Hawkins, M.; O'Shaughnessy, J. Phase III trial of nanoparticle albumin-bound paclitaxel compared with polyethylated castor oil-based paclitaxel in women with breast cancer. J. Clin. Oncol. 2005, 23, 7794-7803.
12. Blanchfield, J.; Toth, I. Lipid, sugar and liposaccharide based delivery systems 2. Curr. Med. Chem. 2004, 11, 2375-2382.
13. Drinnan, N. B.; Vari, F. Aspects of the stability and bioavailability of carbohydrates and carbohydrate derivatives. Mini Rev. Med. Chem. 2003, 3, 633-649.
14. Macmillan, D.; Daines, A. M. Recent developments in the synthesis and discovery of oligosaccharides and glycoconjugates for the treatment of disease. Curr. Med. Chem. 2003, 10, 2733-2773.
15. Koreeda, M.; Houston, T. A.; Shull, B. K.; Klemke, E.; Tuinman, R. J. Iodine catalyzed Ferrier reaction 1. A mild and highly versatile glycosylation of hydroxy and phenolic groups. Synlett. 1995, 90-92.
16. Service, R. F. Science 2001, 291, 2342-2342.
17. Winum, J.-V.; Casini, A.; Mincione, F.; Starnotti, M.; Montero, J.-L.; Scozzafava, A.; Supuran, C. T. Carbonic anhydrase inhibitors: N-(p-Sulfamoylphenyl)-α-n-glycopyranosylamines as topically acting antiglaucoma agents in hypertensive rabbits. Bioorg. Med. Chem. Lett. 2004, 14, 225-229.
18. Wilkinson, B. L.; Bornaghi, L. F.; Poulsen, S.-A.; Houston, T. A. Synthetic utility of glycosyl triazoles in carbohydrate chemistry. Tetrahedron 2006, 62, 8115-8125.
19. Mincione, F.; Starnotti, M.; Menabuoni, L.; Scozzafava, A.; Casini, A.; Supuran, C. T. Carbonic anhydrase inhibitors: 4-Sulfamoyl-benzenecarboxamides and 4-chloro-3-sulfamoyl-benzenecarboxamides with strong topical antiglaucoma properties. Bioorg. Med. Chem. Lett. 2001, 11, 1787-1791.
20. Kunz, H.; Waldmann, H. Construction of disaccharide N-glyco-peptides- Synthesis of the linkage region of the transmembrane-neuraminidase of an influenza virus. Angew. Chem., Int. Ed. Engl. 1985, 24, 883-885.
21. Cottaz, S.; Brimacombe, J. S.; Ferguson, M. A. J. An imino-linked carba-disaccharide α-D-mannosidase inhibitor. Carbohydr. Res. 1993, 247, 341-345.
22. Rostovtsev, V. V.; Green, L. G.; Fokin, V. V.; Sharpless, K. B. A stepwise Huisgen cycloaddition process: Copper(I)-catalyzed regioselective "ligation" of azides and terminal alkynes. Angew. Chem., Int. Ed. 2002, 41, 2596-2599.
23. Khalifah, R. G. The carbon dioxide hydration activity of carbonic anhydrase. J. Biol Chem. 1971, 246, 2561-2573.
24. Winum, J.-Y.; Vullo, D.; Casini, A.; Montero, J.-L.; Scozzafava, A.; Supuran, C. T. Carbonic anhydrase inhibitors: Inhibition of transmembrane, tumor-associated isozyme IX, and cytosolic isozymes I and II with aliphatic sulfamates. J. Med. Chem. 2003, 46, 5471-5477.
25. Svastova, E.; Hulikova, A.; Rafajova, M.; Zatovicova, M.; Gibadulinova, A.; Casini, A.; Cecchi, A.; Scozzafava, A.; Supuran, C. T.; Pastorek, J.; Pastorekova, S. Hypoxia activates the capacity of tumor-associated carbonic anhydrase IX to acidify extracellular pH. FEBS Lett. 2004, 577, 439-445.
26. Winum, J.-Y.; Vullo, D.; Casini, A.; Montero, J.-L.; Scozzafava, A.; Supuran, C. T. Carbonic anhydrase inhibitors. Inhibition of cytosolic isozymes I and II and transmembrane, tumor-associated isozyme IX with sulfamates including EMATE also acting as steroid sulfatase inhibitors. J. Med. Chem. 2003, 46, 2197-2204.
27. Cecchi, A.; Hulikova, A.; Pastorek, J.; Pastorekova, S.; Scozzafava, A.; Winum, J.-Y.; Montero, J.-L.; Supuran, C. T. Carbonic anhydrase inhibitors. Sulfonamides inhibit isozyme IX mediated acidification of hypoxic tumors. Fluorescent sulfonamides design as probes of membrane-bound carbonic anhydrase isozymes involvement in tumorigenesis. J. Med. Chem. 2005, 48, 4834-484.
28. Casey, J. R.; Morgan, P. E.; Vullo, D.; Scozzafava, A.; Mastrolorenzo, A.; Supuran, C. T. Carbonic anhydrase inhibitors. Design of selective, membrane-impermeant inhibitors targeting the human tumor-associated isozyme IX. J. Med. Chem. 2004, 47, 2337-2347.
29. Hang, H. C.; Bertozzi, C. R. Chemoselective approaches to glycoprotein assembly. Acc. Chem. Res. 2001, 34, 727-736.
30. Vullo, D.; Franchi, M.; Gallori, E.; Pastorek, J.; Scozzafava, A.; Pastorekova, S.; Supuran, C. T. Carbonic anhydrase inhibitors. Inhibition of the tumor-associated isozyme IX with aromatic and heterocyclic sulfonamides. Bioorg. Med. Chem. Lett. 2003, 13, 1005-1009.